• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸主动脉腔内修复术中左锁骨下动脉覆盖后的短期和中期结果。

Short and midterm results after left subclavian artery coverage during endovascular repair of the thoracic aorta.

作者信息

Kotelis Drosos, Geisbüsch Philipp, Hinz Ulf, Hyhlik-Dürr Alexander, von Tengg-Kobligk Hendrik, Allenberg Jens R, Böckler Dittmar

机构信息

Department of Vascular and Endovascular Surgery, University of Heidelberg, Heidelberg, Germany.

出版信息

J Vasc Surg. 2009 Dec;50(6):1285-92. doi: 10.1016/j.jvs.2009.07.106. Epub 2009 Oct 17.

DOI:10.1016/j.jvs.2009.07.106
PMID:19837529
Abstract

BACKGROUND

To analyze the sequelae of the intentional left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR).

METHODS

Retrospective analysis of prospectively collected data in a single center. Between March 1997 and October 2008, 88 of 220 patients (40%) had thoracic aortic lesions that required LSA coverage during TEVAR. Thirty-four of our patients (39%) were treated under urgent or emergent conditions for acute pathologies. The proximal landing zone was zone 0 in 10 patients (11%), zone 1 in 24 patients (27%), and zone 2 in 54 patients (61%). Debranching procedures of the supra-aortic vessels were performed in patients who were to undergo zone 0 or zone 1 deployment. Primary LSA revascularization was performed in 22 of the 88 patients (25%) at a median of 6 days before TEVAR. Median follow-up was 26.4 months (1-98 months).

RESULTS

Technical success was achieved in 97%. Five primary (9%) and two secondary (4%) type Ia endoleaks in patients who underwent zone 2 deployment were observed and required further interventions. Fourteen (16%) primary type II endoleaks were observed; 10 of them fed by the LSA. Paraplegia rate was lower in patients with LSA coverage without revascularization than in other patients (1.5% vs 1.9%; odds ratio [OR], 0.774; 95% confidence interval [CI], 0.038-6.173; P = 1.000). Prior or concomitant infrarenal aortic replacement (P = .0019), renal insufficiency (glomerular filtration rate < 90 mL/min/1.73 m(2)) (P = .0024) and long segment aortic coverage (>200 mm) (P = .0157) were associated with significant higher risk of postoperative paraplegia. Stroke rate was lower in patients with LSA coverage without revascularization than in other patients (3% vs 3.9%; OR, 0.570; 95% CI, 0.118-2.761; P = .7269). Two patients (3%) developed left upper extremity symptoms and another two patients (3%) subclavian steal syndrome and required secondary LSA revascularization. The technical success rate for LSA revascularization was 94%.

CONCLUSION

By using a selective approach to the LSA revascularization, coverage of the LSA can be used to extend the proximal seal zone for TEVAR without increasing the risk of spinal cord ischemia or stroke. Indications for revascularization include long segment aortic coverage, prior or concomitant infrarenal aortic replacement, and renal insufficiency. In addition, a hypoplastic right vertebral artery, a patent left internal mammary artery graft, and a functioning dialysis fistula in the left arm would also be indications to perform revascularization.

摘要

背景

分析胸主动脉腔内修复术(TEVAR)期间故意覆盖左锁骨下动脉(LSA)的后遗症。

方法

对单中心前瞻性收集的数据进行回顾性分析。1997年3月至2008年10月期间,220例患者中有88例(40%)患有胸主动脉病变,在TEVAR期间需要覆盖LSA。我们的34例患者(39%)因急性病变在紧急或急诊情况下接受治疗。近端锚定区在10例患者(11%)中为0区,24例患者(27%)中为1区,54例患者(61%)中为2区。对于将接受0区或1区植入的患者,进行了主动脉弓上血管的去分支手术。88例患者中有22例(25%)在TEVAR前中位时间6天进行了原发性LSA血运重建。中位随访时间为26.4个月(1 - 98个月)。

结果

技术成功率为97%。在接受2区植入的患者中观察到5例原发性(9%)和2例继发性(4%)Ia型内漏,并需要进一步干预。观察到14例(16%)原发性II型内漏;其中10例由LSA供血。未进行血运重建而覆盖LSA的患者截瘫率低于其他患者(1.5%对1.9%;优势比[OR],0.774;95%置信区间[CI],0.038 - 6.173;P = 1.000)。既往或同期肾下腹主动脉置换(P = .0019)、肾功能不全(肾小球滤过率<90 mL/min/1.73 m²)(P = .0024)以及长节段主动脉覆盖(>200 mm)(P = .0157)与术后截瘫风险显著升高相关。未进行血运重建而覆盖LSA的患者卒中率低于其他患者(3%对3.9%;OR,0.570;95% CI,0.118 - 2.761;P = .7269)。2例患者(3%)出现左上肢症状,另外2例患者(3%)出现锁骨下动脉窃血综合征,需要进行继发性LSA血运重建。LSA血运重建的技术成功率为94%。

结论

通过采用选择性LSA血运重建方法,覆盖LSA可用于扩展TEVAR的近端密封区,而不增加脊髓缺血或卒中风险。血运重建的指征包括长节段主动脉覆盖、既往或同期肾下腹主动脉置换以及肾功能不全。此外,右椎动脉发育不全、左乳内动脉移植血管通畅以及左臂有功能的透析瘘也将是进行血运重建的指征。

相似文献

1
Short and midterm results after left subclavian artery coverage during endovascular repair of the thoracic aorta.胸主动脉腔内修复术中左锁骨下动脉覆盖后的短期和中期结果。
J Vasc Surg. 2009 Dec;50(6):1285-92. doi: 10.1016/j.jvs.2009.07.106. Epub 2009 Oct 17.
2
In situ laser fenestration during emergent thoracic endovascular aortic repair is an effective method for left subclavian artery revascularization.在急诊性胸主动脉腔内修复术中进行原位激光开窗是一种有效的左锁骨下动脉血运重建方法。
J Vasc Surg. 2013 Nov;58(5):1171-7. doi: 10.1016/j.jvs.2013.04.045. Epub 2013 Jun 5.
3
Left subclavian artery revascularization in zone 2 thoracic endovascular aortic repair is associated with lower stroke risk across all aortic diseases.在2区胸段血管腔内主动脉修复术中,左锁骨下动脉血运重建与所有主动脉疾病的较低中风风险相关。
J Vasc Surg. 2017 May;65(5):1270-1279. doi: 10.1016/j.jvs.2016.10.111. Epub 2017 Feb 16.
4
Intentional coverage of the left subclavian artery during endovascular repair of traumatic descending thoracic aortic transection.在创伤性降主动脉夹层的血管内修复过程中,故意覆盖左锁骨下动脉。
J Vasc Surg. 2013 Mar;57(3):684-690.e1. doi: 10.1016/j.jvs.2012.08.119. Epub 2012 Nov 20.
5
Left subclavian artery coverage during thoracic endovascular aortic repair: a single-center experience.胸主动脉腔内修复术中左锁骨下动脉覆盖:单中心经验
J Vasc Surg. 2008 Sep;48(3):555-60. doi: 10.1016/j.jvs.2008.03.060. Epub 2008 Jun 24.
6
Meta-analysis of Left Subclavian Artery Coverage With and Without Revascularization in Thoracic Endovascular Aortic Repair.胸主动脉腔内修复术中左锁骨下动脉覆盖伴或不伴血运重建的Meta分析
J Endovasc Ther. 2016 Aug;23(4):634-41. doi: 10.1177/1526602816651417. Epub 2016 May 25.
7
Management of the left subclavian artery during TEVAR - complications and mid-term follow-up.胸主动脉腔内修复术中左锁骨下动脉的处理——并发症及中期随访
Vasa. 2018 Aug;47(5):387-392. doi: 10.1024/0301-1526/a000713. Epub 2018 May 23.
8
Intrathoracic subclavian artery aneurysm repair in the thoracic endovascular aortic repair era.胸主动脉腔内修复时代的胸内锁骨下动脉动脉瘤修复。
J Vasc Surg. 2013 Apr;57(4):915-25. doi: 10.1016/j.jvs.2012.09.074. Epub 2013 Jan 30.
9
Association of left subclavian artery coverage without revascularization and spinal cord ischemia in patients undergoing thoracic endovascular aortic repair: A Vascular Quality Initiative® analysis.接受胸段血管腔内主动脉修复术患者中未进行血运重建的左锁骨下动脉覆盖与脊髓缺血的相关性:血管质量改进计划®分析
Vascular. 2017 Dec;25(6):587-597. doi: 10.1177/1708538116681910. Epub 2017 Oct 12.
10
Reevaluating the need for left subclavian artery revascularization with thoracic endovascular aortic repair.通过胸主动脉腔内修复术重新评估左锁骨下动脉血运重建的必要性。
Ann Thorac Surg. 2007 Oct;84(4):1201-5; discussion 1205. doi: 10.1016/j.athoracsur.2007.05.020.

引用本文的文献

1
Preoperative and Postoperative Arterial Adaptation in Patients with Acute Aortic Dissection.急性主动脉夹层患者术前和术后的动脉适应性
J Clin Med. 2024 Dec 3;13(23):7362. doi: 10.3390/jcm13237362.
2
[Cost-revenue aspects of endovascular treatment of distal aortic arch pathologies with respect to the introduction of a new thoracic side-branch prosthesis].[关于新型胸侧支假体引入对远端主动脉弓病变进行血管内治疗的成本-收益方面]
Chirurgie (Heidelb). 2024 Jun;95(6):473-479. doi: 10.1007/s00104-024-02072-3. Epub 2024 Mar 18.
3
Endovascular Strategies for Aortic Arch When US Food and Drug Administration-Approved Devices Are Not Available.
当美国食品药品监督管理局批准的器械不可用时,主动脉弓的血管内治疗策略
Tex Heart Inst J. 2024 Mar 14;51(1). doi: 10.14503/THIJ-24-8391.
4
Atypical presentation of subclavian steal syndrome with left sided sensorineural deafness.伴有左侧感音神经性耳聋的锁骨下动脉盗血综合征非典型表现。
J Vasc Surg Cases Innov Tech. 2023 Aug 30;9(4):101308. doi: 10.1016/j.jvscit.2023.101308. eCollection 2023 Dec.
5
Collateral network concept in 2023.2023年的侧支循环网络概念。
Ann Cardiothorac Surg. 2023 Sep 28;12(5):450-462. doi: 10.21037/acs-2023-scp-15. Epub 2023 Jul 20.
6
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合委员会临床实践指南的报告。
J Thorac Cardiovasc Surg. 2023 Nov;166(5):e182-e331. doi: 10.1016/j.jtcvs.2023.04.023. Epub 2023 Jun 28.
7
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2.
8
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2.
9
Thoracic Endovascular Aortic Repair (TEVAR) First in Patients with Lower Limb Ischemia in Complicated Type B Aortic Dissection: Clinical Outcome and Morphology.胸主动脉腔内修复术(TEVAR)在复杂B型主动脉夹层合并下肢缺血患者中的首次应用:临床结果与形态学
J Clin Med. 2022 Jul 17;11(14):4154. doi: 10.3390/jcm11144154.
10
Outcomes of single physician-modified fenestrated stent grafts for endovascular repair of thoracic aortic lesions involving the distal aortic arch.单医生改良开窗支架移植物腔内修复累及主动脉弓远端胸主动脉病变的结果。
Interact Cardiovasc Thorac Surg. 2021 Apr 19;32(4):560-565. doi: 10.1093/icvts/ivaa295.